SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
ageas SA/NV (AGESY) trades at a trailing P/E of 9.2, forward P/E of 8.8. Trailing earnings yield is 10.88%, forward earnings yield 11.33%. PEG 0.21 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (9.2); PEG ≤ 1.0 — Peter Lynch undervalued (0.21); earnings yield beats bond yields (10.88%).
- Forward P/E 8.8 (down from trailing 9.2) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.21 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 10.88% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 11.33% as earnings recover.
Overall SharesGrow Score: 81/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AGESY
Valuation Multiples
P/E (TTM)9.2
Forward P/E8.8
PEG Ratio0.21
Forward PEG2.21
P/B Ratio0.00
P/S Ratio0.80
EV/EBITDA0.0
Per Share Data
EPS (TTM)$8.75
Forward EPS (Est.)$9.10
Book Value / Share$0.00
Revenue / Share$100.25
FCF / Share$0.00
Yields & Fair Value
Earnings Yield10.88%
Forward Earnings Yield11.33%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.13 |
$13.45B |
$27.1M |
0.2% |
| 2017 |
$3.09 |
$11.85B |
$623.2M |
5.3% |
| 2018 |
$4.11 |
$11.03B |
$809.1M |
7.3% |
| 2019 |
$5.08 |
$14.19B |
$979M |
6.9% |
| 2020 |
$6.07 |
$11.63B |
$1.14B |
9.8% |
| 2021 |
$4.52 |
$13.04B |
$845M |
6.5% |
| 2022 |
$5.49 |
$9.58B |
$1.1B |
11.4% |
| 2023 |
$5.18 |
$7.88B |
$953M |
12.1% |
| 2024 |
$6.09 |
$8.48B |
$1.12B |
13.2% |
| 2025 |
$8.75 |
$18.85B |
$1.64B |
8.7% |
